News

     
                  No items found     

2025

2024

2023

2022

2021

2020

May 28, 2020

Caladrius Biosciences Closes $4.3 Million Registered Direct Offering Priced At-The-Market under NASDAQ Rules

VIEW PRESS RELEASE

April 27, 2020

Caladrius Biosciences Closes $5.0 Million Registered Direct Offering Priced At-The-Market under NASDAQ Rules

VIEW PRESS RELEASE

April 21, 2020

CYCLACEL Announces Pricing of $20.0 Million Public Offering

VIEW PRESS RELEASE

April 16, 2020

Arcturus Therapeutics Announces Pricing of $70.0 Million Offering of Public Stock

VIEW PRESS RELEASE

February 28, 2020

Celsion Corporation Prices $4.8 Million Registered Direct Offering

VIEW PRESS RELEASE

2019

December 23, 2019

Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock

VIEW PRESS RELEASE

December 12, 2019

SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants

VIEW PRESS RELEASE

October 22, 2019

Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering

VIEW PRESS RELEASE

September 26, 2019

Vaxart Announces Pricing of $8 Million Underwritten Public Offering

VIEW PRESS RELEASE

August 6, 2019

BioCardia Announces Closing of $10.0 Million Public Offering

VIEW PRESS RELEASE